- Home
- WLKP vs CATX Comparison
WLKP vs CATX Comparison
Compare WLKP & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLKP
- CATX
- Stock Information
- Founded
- WLKP 2014
- CATX 1983
- Country
- WLKP United States
- CATX United States
- Employees
- WLKP N/A
- CATX N/A
- Industry
- WLKP Major Chemicals
- CATX Medical/Dental Instruments
- Sector
- WLKP Industrials
- CATX Health Care
- Exchange
- WLKP Nasdaq
- CATX Nasdaq
- Market Cap
- WLKP 819.6M
- CATX 782.7M
- IPO Year
- WLKP 2014
- CATX N/A
- Fundamental
- Price
- WLKP $23.00
- CATX $2.86
- Analyst Decision
- WLKP
- CATX Strong Buy
- Analyst Count
- WLKP 0
- CATX 9
- Target Price
- WLKP N/A
- CATX $17.25
- AVG Volume (30 Days)
- WLKP 41.8K
- CATX 2.3M
- Earning Date
- WLKP 02-18-2025
- CATX 02-12-2025
- Dividend Yield
- WLKP 8.21%
- CATX N/A
- EPS Growth
- WLKP 8.66
- CATX N/A
- EPS
- WLKP 1.75
- CATX N/A
- Revenue
- WLKP $1,143,109,000.00
- CATX $1,557,000.00
- Revenue This Year
- WLKP N/A
- CATX N/A
- Revenue Next Year
- WLKP $5.56
- CATX N/A
- P/E Ratio
- WLKP $13.11
- CATX N/A
- Revenue Growth
- WLKP N/A
- CATX N/A
- 52 Week Low
- WLKP $21.19
- CATX $2.70
- 52 Week High
- WLKP $24.34
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- WLKP 37.98
- CATX 19.60
- Support Level
- WLKP $23.68
- CATX $2.70
- Resistance Level
- WLKP $24.20
- CATX $3.60
- Average True Range (ATR)
- WLKP 0.46
- CATX 0.31
- MACD
- WLKP -0.15
- CATX 0.20
- Stochastic Oscillator
- WLKP 0.00
- CATX 10.67
About WLKP Westlake Chemical Partners LP Common Units representing limited partner interests
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.